Study to Analyze Mutations in V600 BRAF Oncogen in Participants With Metastatic Melanoma

Clinical trial NCT02663232 · COMPLETED

Trial details

NCT number: NCT02663232
Sponsor: Hoffmann-La Roche
Status: COMPLETED
Study type: OBSERVATIONAL

Metastatic Cancers

Start date: 2013-06-01
Primary completion: 2014-10-01
Enrollment: 264

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.